AbCellera Biologics Inc.
US ˙ NasdaqGS ˙ CA00288U1066

SecurityABCL / AbCellera Biologics Inc.
InstitutionAdvisor Group Holdings, Inc.
Latest Disclosed Ownership348,978 shares
Latest Disclosed Value $ 1,217,904
Advisor Group Holdings, Inc. reports 0.48% increase in ownership of ABCL / AbCellera Biologics Inc.

On May 15, 2026 - Advisor Group Holdings, Inc. filed a 13F-HR form disclosing ownership of 348,978 shares of AbCellera Biologics Inc. (US:ABCL) valued at $1,217,933 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 347,321 shares of AbCellera Biologics Inc.. This represents a change in shares of 0.48% during the quarter. The current value of the position is $1,961,256 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 348,978 1,657 0.48 1,218 2.53 0.0010
2026-02-17 2025-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 347,321 4,246 1.24 1,188 -17.28 0.0017
2025-11-14 2025-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 343,075 75,074 28.01 1,435 56.15 0.0020
2025-09-04 2025-06-30 13F/A-1 ABCELLERA BIOLOGICS COM 00288U106 268,001 52,227 24.20 919 91.06 0.0016
2025-08-13 2025-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 131,247 -84,527 385 0.0008
2025-05-12 2025-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 215,774 83,760 63.45 481 24.61 0.0011
2025-06-06 2024-12-31 13F/A-1 ABCELLERA BIOLOGICS COM 00288U106 132,014 27,760 26.63 387 42.44 0.0009
2025-02-07 2024-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 104,365 111 272 0.0007
2024-11-13 2024-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 104,254 -2,223 -2.09 271 -13.97 0.0006
2024-08-13 2024-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 106,477 1,630 1.55 315 -33.54 0.0007
2024-05-10 2024-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 104,847 2,689 2.63 475 -18.70 0.0011
2024-02-12 2023-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 102,158 -95,633 -48.35 583 -35.86 0.0010
2023-11-13 2023-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 197,791 106,970 117.78 910 55.12 0.0013
2023-08-21 2023-06-30 13F/A-1 ABCELLERA BIOLOGICS COM 00288U106 90,821 6,371 7.54 587 -7.86 0.0011
2023-08-10 2023-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 90,821 6,371 587 0.0002
2023-05-12 2023-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 84,450 9,784 13.10 637 -15.87 0.0012
2023-02-10 2022-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 74,666 4,799 6.87 757 9.41 0.0015
2022-11-14 2022-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 69,867 21,336 43.96 691 33.66 0.0016
2022-08-10 2022-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 48,531 7,832 19.24 517 30.23 0.0011
2022-05-04 2022-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 40,699 13,877 51.74 397 3.66 0.0008
2022-02-03 2021-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 26,822 13,738 105.00 383 46.18 0.0007
2021-11-05 2021-09-30 13F ABCELLERA BIOLOGICS COM 00288U106 13,084 6,987 114.60 262 96.99 0.0005
2021-08-02 2021-06-30 13F ABCELLERA BIOLOGICS COM 00288U106 6,097 1,526 33.38 133 -14.19 0.0003
2021-05-13 2021-03-31 13F ABCELLERA BIOLOGICS COM 00288U106 4,571 3,121 215.24 155 167.24 0.0004
2021-02-10 2020-12-31 13F ABCELLERA BIOLOGICS COM 00288U106 1,450 1,450 58 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.